menu
    • menu

    Company profile for BioNTech

    NEW Drugs in Dev: 64
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen ...
    BioNTech SE is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all of the building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioNTechGermany Flag
    Country
    Country
    Germany
    Address
    Address
    An der Goldgrube 12 D-55131 Mainz
    Telephone
    Telephone
    +49-6131-9084-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biontech.com/int/en/home.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biontech-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biontech_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    #ASCO26: New VEGF Bispecific Data From BioNTech-BMS, Pfizer-3SBio
    #ASCO26: New VEGF Bispecific Data From BioNTech-BMS, Pfizer-3SBio

    21 May 2026

    // ENDPOINTS

    https://endpoints.news/new-data-released-for-vegf-bispecifics-from-biontech-bms-pfizer-3sbio/

    ENDPOINTS
    21 May 2026
    Share Share
    BioNTech Closes Multiple Manufacturing Plants, Affecting 1,860
    BioNTech Closes Multiple Manufacturing Plants, Affecting 1,860

    06 May 2026

    // BIOSPACE

    https://www.biospace.com/business/biontech-moves-to-close-multiple-manufacturing-plants-affecting-1-860-jobs

    BIOSPACE
    06 May 2026
    Share Share
    BioNTech Reveals Q1 2026 Financials And Corporate Update
    BioNTech Reveals Q1 2026 Financials And Corporate Update

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3287464/0/en/biontech-announces-first-quarter-2026-financial-results-and-corporate-update.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share
    BioNTech to Report Q1 2026 Financial Results and Corporate Update
    BioNTech to Report Q1 2026 Financial Results and Corporate Update

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3277750/0/en/biontech-to-report-first-quarter-2026-financial-results-and-corporate-update-on-may-5-2026.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    BioNTech, DualityBio Tout ADC Efficacy in Endometrial Cancer
    BioNTech, DualityBio Tout ADC Efficacy in Endometrial Cancer

    13 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/biontech-dualitybio-tout-clinically-meaningful-efficacy-for-adc-in-mid-stage-endometrial-cancer-trial

    BIOSPACE
    13 Apr 2026
    Share Share
    BioNtech And Dualitybio's Trastuzumab Pamirtecan Shows Efficacy
    BioNtech And Dualitybio's Trastuzumab Pamirtecan Shows Efficacy

    11 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/11/3272109/0/en/BioNTech-and-DualityBio-s-Antibody-Drug-Conjugate-Trastuzumab-Pamirtecan-Demonstrated-Clinically-Meaningful-Efficacy-in-Patients-with-HER2-Expressing-Recurrent-Endometrial-Cancer.html

    GLOBENEWSWIRE
    11 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search